This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laverdiere, C. Articles by Gorlick, R. Search for Related Content PubMed PubMed Citation Articles by Laverdiere, C. Articles by Gorlick, R.

Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma

Authors' Affiliations: Departments of ¹ Pediatrics, ² Orthopedic Surgery Service, ³ Epidemiology and Biostatistics, and ⁴ Pathology, Memorial Sloan-Kettering Cancer Center and, ⁵ Section of Hematology and Oncology, Department of Pediatrics, Children's Hospital at Montefiore, New York, New York

Requests for reprints: Richard Gorlick, Department of Pediatrics, The Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Rosenthal 3rd Floor, Bronx, NY 10467. Phone: 718-741-2333; Fax: 718-920-6506; E-mail: rgorlick{at}montefiore.org.

Purpose: To determine if osteosarcoma cells express chemokine receptors and if their presence or absence relates to clinical features.

Experimental Design: Using fluorescent quantitative real-time PCR, the pattern of 17 chemokine receptors in 3 osteosarcoma cell lines and 68 osteosarcoma patient samples was analyzed.

Results: The expression of the chemokine receptors was generally low among the cell lines. In the high-grade osteosarcoma patient samples (n = 47), CXCR4 was the most commonly expressed (63%) and its expression level was inversely correlated to overall survival (P < 0.0001), event-free survival (P < 0.001), and metastasis-free survival (MFS; P = 0.002). There was also a correlation between the expression level of CXCR4 and the presence of metastasis at diagnosis (P = 0.002). CCR7 was expressed in 43% of the samples and its expression level was inversely correlated with overall survival (P = 0.03) and MFS (P = 0.007). CCR10 mRNA expression level was inversely correlated with MFS (P = 0.009). There was no association between the expression of CXCR4, CCR7, and CCR10. Of the 26 samples studied for stromal cell–derived factor-1 expression, 77% expressed it, but there was no correlation with the clinical variables or CXCR4 expression. Multivariate analysis revealed that mRNA expression level of CXCR4 was the only significant variable for overall survival (P = 0.0006), event-free survival (P = 0.004), and MFS (P = 0.025).

Conclusions: These data suggest that CXCR4 could be useful as a prognostic factor and as a predictor of potential metastatic development in osteosarcoma. If further studies confirm that it is relevant to metastases in this disease, it could represent a new therapeutic target.

Key Words: chemokine receptors • bone cancer • metastasis

This article has been cited by other articles:

				L. Cantiani, M. C. Manara, C. Zucchini, P. De Sanctis, M. Zuntini, L. Valvassori, M. Serra, M. Olivero, M. F. Di Renzo, M. P. Colombo, et al. Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling Cancer Res., August 15, 2007; 67(16): 7675 - 7685. [Abstract] [Full Text] [PDF]

				I. von Luettichau, M. Nathrath, S. Burdach, R. Huss, S. Segerer, and P. J. Nelson Mononuclear Infiltrates in Osteosarcoma and Chemokine Receptor Expression Clin. Cancer Res., September 1, 2006; 12(17): 5253 - 5254. [Full Text] [PDF]